Search Results
11 protocol(s) meet the specified criteria
Testing the Addition of the Oral Medication Ibrutinib to Autologous Stem Cell Transplantation for Patients with Relapsed Diffuse Large B-Cell Lymphoma

Pilot Trial Evaluating the Combination of Reolysin and Carfilzomib in Multiple Myeloma

Intermediate-size, Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease

Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adult Patients with Hematologic Malignancies and Other Indications

Phase I/II Study of Treg/Tcon Addback to CD34 Selected Partially Matched Related Donor Stem Cells with Myeloablative Conditioning for High-Risk Hematologic Malignancies

Single-Arm Study to Assess the Safety of Transplantation with Human Placental-Derived Stem Cells Combined with Unrelated and Related Cord Blood in Subjects with Certain Malignant Hematologic Diseases and Non-Malignant Disorders

Multicenter Biologic Assignment Trial Comparing Reduced Intensity Allogeneic Hematopoietic Cell Transplant to Hypomethylating Therapy or Best Supportive Care in Patients Aged 50-75 with Intermediate-2 and High-Risk Myelodysplastic Syndrome

Pilot Study for the Treatment of Steroid-Refractory Sclerodermatous Chronic Graft-Versus-Host Disease (GVHD) with GDC-0449

Phase III, Randomized, Adaptive Study Comparing the Efficacy and Safety of Defibrotide versus Best Supportive Care in the Prevention of Hepatic Veno-Occlusive Disease in Adult and Pediatric Patients Undergoing Hematopoietic Stem Cell Transplant

Allogeneic Stem Cell Transplantation for Multiple Myeloma and Myelofibrosis

Phase I, Non-Randomized, Open-Label/Phase II Randomized, Blinded Study of ProTmune versus Non-Programmed Mobilized Peripheral Blood Cells for Allogeneic Hematopoietic Cell Transplantation in Adult Subjects with Hematologic Malignancies